In the future, it will be important to determine if NRF3 and HSPA5 directly bind to each other, how the interaction of NRF3 with HSPA5 regulates the amount and localization of this ER chaperone, and if additional mechanisms contribute to the tumor‐suppressive effect of NRF3 in keratinocytes. Here, NFE2L3 is linked to neoplasm.